Physician profile
Nitul Mathur
NPI 1114972205
$3,746.15
in general payments reported to CMS, 2019-2025
23 companies · $569 in 2025
The $569 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,101 · 2022: $738 · 2023: $1,144 · 2024: $195 · 2025: $569.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,908.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,907.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $469.90 | 2021-2023 | Farxiga |
| Novo Nordisk INC | $428.65 | 2023-2025 | Ozempic, Wegovy, Rybelsus |
| Janssen Pharmaceuticals, INC | $391.38 | 2021-2023 | Xarelto |
| Edwards Lifesciences Corporation | $309.89 | 2021-2024 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| E.R. Squibb & Sons, L.L.C. | $283.16 | 2021-2025 | Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $227.71 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $227.64 | 2021-2025 | Verquvo, Capvaxive |
| Pfizer INC. | $223.99 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $216.20 | 2022-2023 | |
| Irhythm Technologies, INC. | $195.14 | 2021-2023 | Zio Xt Patch |
| Genentech USA, INC. | $148.09 | 2021 | |
| Intuitive Surgical, INC. | $124.99 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $117.96 | 2021-2025 | Lifevest |
| Amgen INC. | $108.09 | 2023-2025 | Repatha, Repatha |
| Abbott Laboratories | $89.09 | 2023-2025 | Jot Dx, Amplatzer Amulet |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $37.83 | 2023 | Inspire |
| Bayer Healthcare Pharmaceuticals INC. | $31.75 | 2023-2025 | |
| Xeris Pharmaceuticals, INC. | $23.55 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $22.22 | 2023 | Inpefa |
| Boston Scientific Corporation | $21.37 | 2023 | Watchman Access System |
| Lantheus Medical Imaging, INC. | $19.29 | 2022 | |
| Biotronik INC. | $14.35 | 2022 | |
| Esperion Therapeutics, INC. | $13.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nitul Mathur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.